UBS Knock-Out ABT/ DE000UK6RMZ4 /
2024-11-11 9:16:23 AM | Chg.+0.02 | Bid2:20:57 PM | Ask2:20:57 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
5.43EUR | +0.37% | 5.42 Bid Size: 5,000 |
5.46 Ask Size: 5,000 |
Abbott Laboratories | 59.2842 USD | 2078-12-31 | Call |
GlobeNewswire
08-06
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
06-06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
05-09
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
03-25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
03-15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
2023-11-14
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
2023-10-19
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer